These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38158896)

  • 1. [Drug therapy's new options in the treatment of the severe irritable bowel syndrome].
    Makarova AA; Ruchkina IN; Diukova GM; Romashkina NV; Indejkina LK; Degterev DA; Parfenov AI
    Ter Arkh; 2023 Oct; 95(8):627-633. PubMed ID: 38158896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Visceral sensitivity in diagnostics and treatment of severe irritated bowel syndrome].
    Makarova AA; Diukova GM; Ruchkina IN; Romashkina NV; Indejkina LK; Degterev DA; Dbar SR; Parfenov AI
    Ter Arkh; 2022 Sep; 94(2S):356-361. PubMed ID: 36468983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Open-Label Pilot Study of Duloxetine in Patients With Irritable Bowel Syndrome and Comorbid Major Depressive Disorder.
    Lewis-Fernández R; Lam P; Lucak S; Galfalvy H; Jackson E; Fried J; Rosario M; de la Cruz AA; Sánchez-Lacay A; Díaz S; Schneier F
    J Clin Psychopharmacol; 2016 Dec; 36(6):710-715. PubMed ID: 27755218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy of Kolofort for the treatment of patients with irritable bowel syndrome].
    Tsukanov VV; Rzhavicheva OS; Vasjutin AV; Dunaevskaja OV; Tonkih JL; Bronnikova EP
    Ter Arkh; 2016; 88(8):40-45. PubMed ID: 27636926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of 5-hydroxytryptophan signaling pathway characteristics in diarrhea-predominant irritable bowel syndrome and ulcerative colitis.
    Yu FY; Huang SG; Zhang HY; Ye H; Chi HG; Zou Y; Lv RX; Zheng XB
    World J Gastroenterol; 2016 Mar; 22(12):3451-9. PubMed ID: 27022227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased intestinal mucosal leptin levels in patients with diarrhea-predominant irritable bowel syndrome.
    Liu DR; Xu XJ; Yao SK
    World J Gastroenterol; 2018 Jan; 24(1):46-57. PubMed ID: 29358881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eluxadoline benefits patients with irritable bowel syndrome with diarrhea in a phase 2 study.
    Dove LS; Lembo A; Randall CW; Fogel R; Andrae D; Davenport JM; McIntyre G; Almenoff JS; Covington PS
    Gastroenterology; 2013 Aug; 145(2):329-38.e1. PubMed ID: 23583433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Multidisciplinary treatment of the patient with a severe irritable bowel syndrome].
    Ruchkina IN; Vyaznikova AA; Indeykina LK; Degterev DA; Parfenov AI
    Ter Arkh; 2020 Apr; 92(2):81-84. PubMed ID: 32598723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of purified clinoptilolite-tuff treatment in patients with irritable bowel syndrome with diarrhea: Randomized controlled trial.
    Anderle K; Wolzt M; Moser G; Keip B; Peter J; Meisslitzer C; Gouya G; Freissmuth M; Tschegg C
    World J Gastroenterol; 2022 Dec; 28(46):6573-6588. PubMed ID: 36569277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of diarrhea in evaluating constipation in irritable bowel syndrome clinical studies.
    Basseri RJ; Kunkel D; Low K; Conklin JL; Pimentel M
    J Clin Gastroenterol; 2011 Oct; 45(9):790-3. PubMed ID: 21301356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixture model analysis identifies irritable bowel syndrome subgroups characterised by specific profiles of gastrointestinal, extraintestinal somatic and psychological symptoms.
    Polster A; Van Oudenhove L; Jones M; Öhman L; Törnblom H; Simrén M
    Aliment Pharmacol Ther; 2017 Sep; 46(5):529-539. PubMed ID: 28671338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered profiles of fecal metabolites correlate with visceral hypersensitivity and may contribute to symptom severity of diarrhea-predominant irritable bowel syndrome.
    Zhang WX; Zhang Y; Qin G; Li KM; Wei W; Li SY; Yao SK
    World J Gastroenterol; 2019 Nov; 25(43):6416-6429. PubMed ID: 31798278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of acute serotonergic modulation on rectal motor function in diarrhea-predominant irritable bowel syndrome and healthy controls.
    van Nieuwenhoven MA; Kilkens TO
    Eur J Gastroenterol Hepatol; 2012 Nov; 24(11):1259-65. PubMed ID: 22890209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-Blind Placebo-Controlled Study of Rifaximin and Lactulose Hydrogen Breath Test in Gulf War Veterans with Irritable Bowel Syndrome.
    Tuteja AK; Talley NJ; Stoddard GJ; Verne GN
    Dig Dis Sci; 2019 Mar; 64(3):838-845. PubMed ID: 30370492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rifaximin Treatment for Individual and Multiple Symptoms of Irritable Bowel Syndrome With Diarrhea: An Analysis Using New End Points.
    Lacy BE; Chang L; Rao SSC; Heimanson Z; Sayuk GS
    Clin Ther; 2023 Mar; 45(3):198-209. PubMed ID: 36922331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of sildenafil on rectal sensitivity and tone in patients with the irritable bowel syndrome.
    Gonçalves de Medeiros MT; de Oliveira RB; dos Santos AA; de Leopoldino DM; Lima MC; Nobre RA; Nobre e Souza MÂ
    Aliment Pharmacol Ther; 2012 Mar; 35(5):577-86. PubMed ID: 22229478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain regions involved in moxibustion-induced analgesia in irritable bowel syndrome with diarrhea: a functional magnetic resonance imaging study.
    Zhu Y; Wu Z; Ma X; Liu H; Bao C; Yang L; Cui Y; Zhou C; Wang X; Wang Y; Zhang Z; Zhang H; Jia H; Wu H
    BMC Complement Altern Med; 2014 Dec; 14():500. PubMed ID: 25516481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of brain-derived neurotrophic factor is correlated with visceral hypersensitivity in patients with diarrhea-predominant irritable bowel syndrome.
    Zhang Y; Qin G; Liu DR; Wang Y; Yao SK
    World J Gastroenterol; 2019 Jan; 25(2):269-281. PubMed ID: 30670915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal membrane permeability and hypersensitivity in the irritable bowel syndrome.
    Zhou Q; Zhang B; Verne GN
    Pain; 2009 Nov; 146(1-2):41-6. PubMed ID: 19595511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IBS patients show frequent fluctuations between loose/watery and hard/lumpy stools: implications for treatment.
    Palsson OS; Baggish JS; Turner MJ; Whitehead WE
    Am J Gastroenterol; 2012 Feb; 107(2):286-95. PubMed ID: 22068664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.